Atara Biotherapeutics’ Executive Turnover and Workforce Cuts Elevate Execution Risk and Threaten Strategic ProgressTip Ranks·Aug 14 at 01:01 AMATRA-0.54%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jul 20 at 07:05 AMBRNS+2.07%VBIO-1.39%
Atara Biotherapeutics files initial beneficial ownership statement for interim CFO Kevin SarneyPUBT·Jul 6 at 03:15 PMATRA-0.54%
Mizuho Securities Sticks to Their Buy Rating for Atara Biotherapeutics (ATRA)Tip Ranks·Jun 21 at 03:16 AMATRA-0.54%
09:00 ETThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRAprnewswire·May 26 at 08:01 AMATRA-0.54%IBBQ-2.69%
ATRA Deadline: Rosen Law Firm Urges Atara Biotherapeutics, Inc. (NASDAQ: ATRA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their RightsMorningStar·May 22 at 02:00 PMATRA-0.54%IBB-2.72%
ATRA FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026MorningStar·May 22 at 08:35 AMATRA-0.54%XBI-3.48%
09:01 ETATRA EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026prnewswire·May 21 at 08:02 AMATRA-0.54%FBT-2.54%
Yanina Grant-Huerta Sells 2,414 Shares of Atara Biotherapeutics (NASDAQ:ATRA) StockMarket Beat·May 20 at 06:05 PMATRA-0.54%LABU-10.71%
